Abbott plans to appeal $1.67 billion patent order

Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.

Comments

• Find It

• Recently Written

  • Eli Lilly’s Lechleiter Not Interested In Big Acquisitions
  • S&P May Pare Credit Ratings On Sanofi-Aventis
  • Bristol-Myers Squibb To Buy Zymogenetics for $885 Million
  • Drug Company Zogenix Plans Initial Public offering
  • Karo Bio Announces That Merck Discontinues Development Of MK-6913 For Hot Flashes
  • Bristol-Myers Squibb to Acquire ZymoGenetics
  • Police arrest two on drug charges
  • Martinez City Council candidates square off
  • Prince of pot’s jailer opposes drug laws
  • Merck schizophrenia drug approved for …

• Categories

  • News

• Monthly Archives

  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • December 1969

• Blogroll

  • Attorney Daily » Drug Injury News
  • Dangerous Drug Lawyer
  • Drugs.com - Pharma News
  • Health Canada RSS - Media Room
  • Lawyers and Settlements :: Drugs/Medical
  • Medication News
  • MedWatch Safety Alert RSS Feed

• Admin

  • Register
  • Log in
  • XHTML

Copyright © 2010 Drug Injury News